Differential calcium leucovorin protection of human lymphoid cell lines from methotrexate

1985 ◽  
Vol 15 (2) ◽  
Author(s):  
GeorgeP. Browman ◽  
Lynda Booker ◽  
Paula Spiegl
1981 ◽  
Vol 23 (1) ◽  
pp. 35-38 ◽  
Author(s):  
Ichiro Matsuda ◽  
Izumi Akaboshi ◽  
Jiro Yamamoto ◽  
Noriyuki Nagata

1993 ◽  
Vol 54 (6) ◽  
pp. 1017-1021 ◽  
Author(s):  
Sigrun Gabius ◽  
Ralf Wawotzny ◽  
Sabine Wilholm ◽  
Ulrikc Martin ◽  
Bernhard Wörmann ◽  
...  

2010 ◽  
Vol 104 (9) ◽  
pp. 967-977 ◽  
Author(s):  
Alberto Martínez ◽  
Chandima S.K. Rajapakse ◽  
Roberto A. Sánchez-Delgado ◽  
Armando Varela-Ramirez ◽  
Carolina Lema ◽  
...  

Blood ◽  
2011 ◽  
Vol 118 (18) ◽  
pp. 4872-4881 ◽  
Author(s):  
Husheng Ding ◽  
Jennifer Hackbarth ◽  
Paula A. Schneider ◽  
Kevin L. Peterson ◽  
X. Wei Meng ◽  
...  

Abstract The mechanism of cytotoxicity of farnesyltransferase inhibitors is incompletely understood and seems to vary depending on the cell type. To identify potential determinants of sensitivity or resistance for study in the accompanying clinical trial (Witzig et al, page 4882), we examined the mechanism of cytotoxicity of tipifarnib in human lymphoid cell lines. Based on initial experiments showing that Jurkat variants lacking Fas-associated death domain or procaspase-8 undergo tipifarnib-induced apoptosis, whereas cells lacking caspase-9 or overexpressing Bcl-2 do not, we examined changes in Bcl-2 family members. Tipifarnib caused dose-dependent up-regulation of Bim in lymphoid cell lines (Jurkat, Molt3, H9, DoHH2, and RL) that undergo tipifarnib-induced apoptosis but not in lines (SKW6.4 and Hs445) that resist tipifarnib-induced apoptosis. Further analysis demonstrated that increased Bim levels reflect inhibition of signaling from c-Raf to MEK1/2 and ERK1/2. Additional experiments showed that down-regulation of the Ras guanine nucleotide exchange factor RasGRP1 diminished tipifarnib sensitivity, suggesting that H-Ras or N-Ras is a critical farnesylation target upstream of c-Raf in lymphoid cells. These results not only trace a pathway through c-Raf to Bim that contributes to tipifarnib cytotoxicity in human lymphoid cells but also identify potential determinants of sensitivity to this agent.


1973 ◽  
Vol 137 (3) ◽  
pp. 838-843 ◽  
Author(s):  
T. H. Hütteroth ◽  
H. Cleve ◽  
S. D. Litwin ◽  
M. D. Poulik

ß2-microglobulin was detected on the cell surface and in the medium of human lymphoid cells established in long-term culture. The secretion of ß2-microglobulin was relatively uniform when different cell lines were compared, whereas IgG production varied widely. κ- and µ-membrane antigens were modulated by specific antibody; ß2-microglobulin was not modulated. Anti-κ and anti-µ antisera had no effect on the expression of membrane ß2-microglobulin, nor had anti-ß2-microglobulin antiserum any effect on the expression of κ- and µ-membrane antigens.


1985 ◽  
Vol 19 (7) ◽  
pp. 780-780
Author(s):  
Peter M Van Der Kraan ◽  
Peter M Van Zandvoort ◽  
Ronney A De Abreu ◽  
Jan A J M Bakkeren ◽  
Jan P R M Van Laarhoven ◽  
...  

1984 ◽  
Vol 12 (18) ◽  
pp. 6995-7006 ◽  
Author(s):  
H.-Gustav Klobeck ◽  
Gabriele Combriato ◽  
Hans G. Zachau

Blood ◽  
1970 ◽  
Vol 35 (4) ◽  
pp. 539-542 ◽  
Author(s):  
SUSAN W. BRODER ◽  
P. R. GLADE ◽  
K. HIRSCHHORN

Abstract A highly purified, non-hemagglutinating PHA used in minimal blastogenic doses was non-toxic to established human lymphoid cell lines. PHA given at the beginning of primary culture or repeatedly throughout the initial six weeks of culture did not interfere with the establishment of peripheral lymphocytes in long-term suspension culture. Permanent cell lines have been obtained following weekly administration of PHA in blastogenic and subthreshold doses. Nonhemagglutinating PHA appeared to be non-toxic to these peripheral lymphocyte cultures and may increase their potential for long-term proliferation.


Sign in / Sign up

Export Citation Format

Share Document